A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation

Huntsville

Anaheim

Beverly Hills

Stockton

Orlando

Sarasota

Atlanta

Canton

Fort Wayne

Iowa City

Cadillac

Kalispell

Fremont

Santa Fe

Albany

Oklahoma City

Allentown

Pottstown

Sellersville

Dallas

Salt Lake City

Bellevue

Minsk

Brussels

Genk

Banja Luka

Mostar

Sarajevo

Tuzla

Calgary

Edmonton

Alberta

Winnipeg

Oshawa

Thunder Bay

Montreal

Sherbrooke

Antofagasta

Osorno

Santiago

Temuco

Daugavpils

Riga

Ventspils

Córdoba

Guadalajara Jalisco

Mexico City

Chisinau

Arkhangelsk

Barnaul

Chelyabinsk

Ivanovo

Kaliningrad

Kazan'

Kemerovo

Krasnodar

Krasnoyarsk

Moscow

N.Novgorod

Novosibirsk

Orenburg

Penza

Perm

Rostov-on-Don

Saint Petersburg

Samara

Saratov

Tomsk

Tula

Tyumen

Volgograd

Yaroslavl

Bardejov

Bratislava

Košice

Lučenec

Prešov

Cherkassy

Chernihiv

Chernivtsy

Dnipro

Donetsk

Ivano-Frankivsk

Kiev

Lutsk

Lviv

Odesa

Poltava

Ternopil

Vinnitsa

Zaporizhzhya